National Cancer Institute; Opportunity for a Cooperative Research Agreement (CRADA) for the Clinical Evaluation of Magnetic Resonance Imaging in Breast Cancer

الملخص

The National Cancer Institute (NCI) seeks major pharmaceutical companies that can effectively pursue the joint research, development, evaluation and commercialization of imaging drugs to be used for magnetic resonance imaging (MRI) in breast cancer. NCI will enter into CRADA negotiations with the sponsor(s) of the selected proposal(s).